| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
July 07, 2005 |
|
|
| |
|
|
| |
|
|
|
Cambridge Healthtech Institute, Cambridge, MA
September 20-21, 2005
Attacking cancer cells on the molecular level is a new therapeutic approach in cancer treatment with a tremendous amount of promise. Many hurdles still limit the overall success of developing drugs that interfere with carcinogenesis. Different strategies are being pursued and some of the most promising, such as signal-transduction inhibitors, apoptosis-inducing substances, cell growth inhibitors, cancer vaccines and screening and profiling technologies will be discussed in this inaugural conference. Important questions will be addressed such as: how to identify new targets, how to increase the effectiveness and specificity of new compounds, how to lower toxic side effects, how to validate specific assays, which targets are active in which group of patients and how to predict the responsiveness.
|
|
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute |
|
|
Invited Speakers:
|
|
Go To http://www.healthtech.com/2005/crx/index.asp for Full Information
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
|
|
|
|
|
|
|
|
Registration:
|
|
Go To http://www.healthtech.com/2005/crx/index.asp for Full Information
|
|
|
E-mail:
|
|
chi@healthtech.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|